Skip to main content
. 2017 May 4;24(1):752–764. doi: 10.1080/10717544.2017.1321060

Figure 2.

Figure 2.

Viability of A549 and A549T cells treated with different concentrations of PTX and PTX-CPPs. (A) Cell viability. (B) IC50. **p < 0.01.